Company: RGNX
Filing Date: 2025-05-19
Form Type: 8-K
Source: 0001193125-25-122456
Chunk: 2

Company: REGENXBIO Inc.
Filing Date: 2025-05-19
Form: 8-K
Item: Item 7.01
Chunk 2
---
Item 7.01      Regulation FD Disclosure.  

On May 19, 2025, the Company issued a press release announcing the closing of the Loan Agreement. The press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

The information in Item 7.01 of this Current Report on Form8-Kand Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to liability under that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.

  Item 9.01      Financial Statements and Exhibits.  

  (d)      Exhibits  

  Exhibit      Description                                                                   
      No.                                                                                    
     99.1      Press Release, dated May 19, 2025.                                            
 ─────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).